Cover Image
Market Research Report
Product code
991394

Europe Peripheral Vascular Devices Market Forecast 2021-2028

Published: | Inkwood Research | 140 Pages | Delivery time: 2-3 business days

Price

Back to Top
Europe Peripheral Vascular Devices Market Forecast 2021-2028
Published: March 1, 2021
Inkwood Research
Content info: 140 Pages
Delivery time: 2-3 business days
  • ALL
  • Description
  • Table of Contents
Description

KEY FINDINGS

The Europe peripheral vascular devices market is projected to grow at a CAGR of 11.32% during the forecast period, 2021-2028. The rising focus on developing newer devices by market players, along with product launches and approvals, offers ample market growth opportunities.

MARKET INSIGHTS

France, Italy, the United Kingdom, Belgium, Poland, Russia, Germany, and Rest of Europe, are evaluated for the Europe peripheral vascular devices market growth analysis. Research and development are prominent in Germany. Also, there is swift adoption of new technology in healthcare, much higher than in other European nations. As per a report, peripheral artery disease affects almost 20% of Germans aged 70 and above. With advancements in endovascular and surgical techniques, the government establishes guidelines that cover distal aorta and atherosclerotic lower extremity artery disease. Such factors are estimated to propel market growth.

In Russia, cardiovascular disease (CVD) is a leading cause of death and disability. The mortality rates due to CVD are high in the Russian Federation compared to the average in Europe. 29.4% of deaths are due to coronary heart disease (CHD), while 17.6% are due to cerebrovascular disease. Several preventive measures are being implemented to promote healthy lifestyles and minimizing risk factors. This will further aid in sustaining CVD mortality and increasing life expectancy. Whereas in Spain, there is a high prevalence of peripheral vascular diseases attributed to poor habits and obesity. Moreover, there is rising disposable income and increasing adoption of advanced technological products. Such factors boost the market growth in Spain.

COMPETITIVE INSIGHTS

Some of the eminent companies in the market are Cardinal Health Inc (CORDIS), Becton, Dickinson And Company, Edwards Lifesciences Corporation, Boston Scientific Corporation, Cook Group, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 36163

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. SURGE IN DEMAND FOR MINIMALLY-INVASIVE PROCEDURES FOR PERIPHERAL ARTERIAL DISEASE
    • 3.1.2. GROWING INCIDENCE OF PERIPHERAL ARTERIAL DISEASE
    • 3.1.3. INCREASING AGING POPULATION AND LIFESTYLE CHANGES
    • 3.1.4. TECHNOLOGICAL ADVANCEMENTS
  • 3.2. KEY RESTRAINTS
    • 3.2.1. STRINGENT REGULATIONS
    • 3.2.2. LACK OF PROPER REIMBURSEMENT POLICIES FOR PERIPHERAL VASCULAR DEVICES
    • 3.2.3. HIGH COMPETITION

4. KEY ANALYTICS

  • 4.1. IMPACT OF COVID-19 ON PERIPHERAL VASCULAR DEVICES MARKET
  • 4.2. KEY INVESTMENT INSIGHTS
  • 4.3. PORTER'S FIVE FORCES ANALYSIS
    • 4.3.1. BUYERS POWER
    • 4.3.2. SUPPLIERS POWER
    • 4.3.3. SUBSTITUTIONS
    • 4.3.4. NEW ENTRANTS
    • 4.3.5. INDUSTRY RIVALRY
  • 4.4. OPPORTUNITY MATRIX
  • 4.5. VENDOR LANDSCAPE

5. MARKET BY DEVICE TYPE

  • 5.1. PERIPHERAL VASCULAR STENTS
    • 5.1.1. SELF EXPANDING PERIPHERAL VASCULAR STENTS
    • 5.1.2. BALLOON EXPANDING PERIPHERAL VASCULAR STENTS
    • 5.1.3. DRUG ELUTING PERIPHERAL VASCULAR STENTS
    • 5.1.4. COVERED STENT
  • 5.2. PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS
    • 5.2.1. STANDARD PTA BALLOON CATHETERS
    • 5.2.2. HIGH-PRESSURE PTA BALLOON CATHETER
    • 5.2.3. LARGE PTA BALLOON CATHETER
    • 5.2.4. SMALL PTA BALLOON CATHETER
    • 5.2.5. SPECIALTY PTA BALLOON CATHETER
    • 5.2.6. DRUG COATED PTA BALLOON CATHETER
  • 5.3. PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) GUIDEWIRES
  • 5.4. ATHERECTOMY DEVICES
  • 5.5. EMBOLIC PROTECTION DEVICES
  • 5.6. INFERIOR VENA CAVA FILTERS
  • 5.7. OTHER DEVICE TYPES

6. GEOGRAPHICAL ANALYSIS

  • 6.1. EUROPE
    • 6.1.1. KEY GROWTH ENABLERS
    • 6.1.2. KEY CHALLENGES
    • 6.1.3. KEY PLAYERS
    • 6.1.4. COUNTRY ANALYSIS
      • 6.1.4.1. UNITED KINGDOM
      • 6.1.4.2. GERMANY
      • 6.1.4.3. FRANCE
      • 6.1.4.4. ITALY
      • 6.1.4.5. RUSSIA
      • 6.1.4.6. BELGIUM
      • 6.1.4.7. POLAND
      • 6.1.4.8. REST OF EUROPE

7. COMPETITIVE LANDSCAPE

  • 7.1. KEY STRATEGIC DEVELOPMENTS
    • 7.1.1. MERGER & ACQUISITIONS
    • 7.1.2. PRODUCT LAUNCH & DEVELOPMENTS
    • 7.1.3. PARTNERSHIP, CONTRACT/AGREEMENT & COLLABORATION
    • 7.1.4. BUSINESS EXPANSION
  • 7.2. COMPANY PROFILES
    • 7.2.1. ABBOTT LABORATORIES
    • 7.2.2. BOSTON SCIENTIFIC CORPORATION
    • 7.2.3. BECTON, DICKINSON AND COMPANY
    • 7.2.4. COOK GROUP
    • 7.2.5. CARDINAL HEALTH INC (CORDIS)
    • 7.2.6. EDWARDS LIFESCIENCES CORPORATION
    • 7.2.7. MEDTRONIC PLC
    • 7.2.8. KONINKLIJKE PHILIPS NV (VOLCANO)
    • 7.2.9. ANGIOSCORE INC (SPECTRANETICS CORPORATION)
    • 7.2.10. TELEFLEX MEDICAL
    • 7.2.11. TERUMO INTERVENTIONAL SYSTEMS INC
    • 7.2.12. ENDOLOGIX

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - PERIPHERAL VASCULAR DEVICES
  • TABLE 2: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY DEVICE TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 3: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY DEVICE TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 4: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY PERIPHERAL VASCULAR STENTS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 5: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY PERIPHERAL VASCULAR STENTS, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 6: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 7: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 8: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 9: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 10: LEADING PLAYERS OPERATING IN EUROPE PERIPHERAL VASCULAR DEVICES MARKET
  • TABLE 11: LIST OF MERGERS & ACQUISITIONS
  • TABLE 12: LIST OF PRODUCTS LAUNCHES & DEVELOPMENTS
  • TABLE 13: LIST OF PARTNERSHIPS & AGREEMENTS
  • TABLE 14: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

  • FIGURE 1: KEY INVESTMENT INSIGHTS
  • FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, GROWTH POTENTIAL, BY DEVICE TYPE, IN 2020
  • FIGURE 6: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY PERIPHERAL VASCULAR STENTS, 2021-2028 (IN $ MILLION)
  • FIGURE 7: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, GROWTH POTENTIAL, BY PERIPHERAL VASCULAR STENTS, IN 2020
  • FIGURE 8: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY SELF EXPANDING PERIPHERAL VASCULAR STENTS, 2021-2028 (IN $ MILLION)
  • FIGURE 9: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY BALLOON EXPANDING PERIPHERAL VASCULAR STENTS, 2021-2028 (IN $ MILLION)
  • FIGURE 10: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY DRUG ELUTING PERIPHERAL VASCULAR STENTS, 2021-2028 (IN $ MILLION)
  • FIGURE 11: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY COVERED STENT, 2021-2026 (IN $ MILLION)
  • FIGURE 12: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS, 2021-2028 (IN $ MILLION)
  • FIGURE 13: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, GROWTH POTENTIAL, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETERS, IN 2020
  • FIGURE 14: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY STANDARD PTA BALLOON CATHETERS, 2021-2028 (IN $ MILLION)
  • FIGURE 15: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY HIGH-PRESSURE PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)
  • FIGURE 16: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY LARGE PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)
  • FIGURE 17: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY SMALL PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)
  • FIGURE 18: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY SPECIALTY PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)
  • FIGURE 19: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY DRUG COATED PTA BALLOON CATHETER, 2021-2028 (IN $ MILLION)
  • FIGURE 20: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) GUIDEWIRES, 2021-2028 (IN $ MILLION)
  • FIGURE 21: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY ATHERECTOMY DEVICES, 2021-2028 (IN $ MILLION)
  • FIGURE 22: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION DEVICES, 2021-2028 (IN $ MILLION)
  • FIGURE 23: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY INFERIOR VENA CAVA FILTERS, 2021-2028 (IN $ MILLION)
  • FIGURE 24: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, BY OTHER DEVICE TYPES, 2021-2028 (IN $ MILLION)
  • FIGURE 25: EUROPE PERIPHERAL VASCULAR DEVICES MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 26: UNITED KINGDOM PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 27: GERMANY PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 28: FRANCE PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 29: ITALY PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 30: RUSSIA PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 31: BELGIUM PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 32: POLAND PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 33: REST OF EUROPE PERIPHERAL VASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)